Dermatology · Goodlettsville, TN
NPI
1235116518
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
201 Bluebird Dr
Goodlettsville, TN, 37072
Phone (615) 859-7546
Groups this clinician bills Medicare through
Medicare paid, 2024
$621K
9,324 services
Medicare patients, 2024
1,678
Average age 76
Drug cost, 2024
$1.5M
2,714 prescriptions
Company payments, 2025
$34K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keith H Loven was code 17003 (destruction skin lesion), 1,627 times for 347 patients. In total Keith H Loven billed 9,324 services in 55 codes, and Medicare paid $621K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,627 | 347 | $4.30 | $6,994 |
| 99213 Office E&M - Established | Office | 1,574 | 1,203 | $55.62 | $88K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 1,058 | 52 | $124.47 | $132K |
| 77280 Radiation Treatment Planning | Office | 1,016 | 46 | $185.65 | $189K |
| 77401 Conventional Radiation Treatment | Office | 990 | 46 | $28.47 | $28K |
| 17000 Destruction Skin Lesion | Office | 640 | 541 | $31.54 | $20K |
| 17110 Destruction Skin Lesion | Office | 577 | 496 | $70.24 | $41K |
| 11102 Skin Biopsy | Office | 443 | 381 | $53.20 | $24K |
| 99214 Office E&M - Established | Office | 283 | 229 | $74.95 | $21K |
| 99212 Office E&M - Established | Office | 213 | 194 | $34.10 | $7,263 |
| 99203 Office E&M - New | Office | 150 | 150 | $58.81 | $8,821 |
| 77336 Radiation Treatment Planning | Office | 119 | 36 | $61.57 | $7,327 |
| 11103 Skin Biopsy | Office | 103 | 78 | $32.02 | $3,298 |
| 77300 Radiation Treatment Planning | Office | 70 | 42 | $46.76 | $3,274 |
| 17262 Destruction Skin Lesion | Office | 59 | 52 | $117.96 | $6,959 |
By year: 2022 $906K for 12,207 services; 2023 $714K for 10,263 services; 2024 $621K for 9,324 services.
Medicare prescription drug claims, 2024
In 2024, the drug Keith H Loven prescribed most often to Medicare patients was Clobetasol Propionate, with 446 prescriptions and refills. In total Keith H Loven wrote 2,714 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 446 | 485 | 267 | $22K |
| Ciclopirox Ciclopirox Olamine | 248 | 289 | 165 | $5,883 |
| Fluorouracil Generic | 245 | 312 | 206 | $22K |
| Triamcinolone Acetonide Generic | 185 | 213 | 123 | $2,698 |
| Imiquimod Generic | 172 | 209 | 113 | $5,865 |
| Ketoconazole Generic | 119 | 137 | 59 | $2,008 |
| Metronidazole Generic | 110 | 115 | 60 | $4,918 |
| Betamethasone Dipropionate Generic | 108 | 108 | 70 | $3,861 |
| Doxycycline Hyclate Generic | 103 | 237 | 58 | $4,283 |
| Finasteride Generic | 92 | 271 | 37 | $648 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 73 | 77 | 50 | $3,859 |
| Tacrolimus Generic | 61 | 67 | 43 | $8,067 |
| Ciclopirox Generic | 49 | 59 | 27 | $2,465 |
| Prednisone Generic | 41 | 60 | 24 | $461 |
| Fluocinonide Generic | 41 | 49 | 21 | $1,493 |
Brand drugs: 224 claims; generic drugs: 2,490 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keith H Loven $34K ($28K in general payments such as food, travel and fees and $5,352 for research) from 30 companies. The largest payer was LEO Pharma Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 40 | $18K |
| Eli Lilly and Company LLY | 1 | $2,952 |
| E.R. Squibb & Sons, L.L.C. BMY | 19 | $2,537 |
| Hoffmann-La Roche Limited ROG.SW | 4 | $2,512 |
| Ucb Sa UCB.BR | 7 | $2,007 |
| Janssen Scientific Affairs, LLC JNJ | 4 | $1,604 |
| UCB, Inc. UCB.BR | 33 | $841 |
| Janssen Biotech, Inc. JNJ | 30 | $710 |
| Abbvie Inc. ABBV | 25 | $421 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $401 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.